Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray
Release Date: 09/23/2024
ENVISIONing Change in Bladder Cancer Care
The UroGist
In this episode of The UroGist, a podcast for urologists, by urologists, host Dr. Mike Louie of UroGen is joined by Dr. Sandip Prasad, Director of Genitourinary Surgical Oncology, Vice-Chair of Urology at Morristown Medical Center/Atlantic Health System, and principal investigator of the ENVISION clinical trial, to discuss recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) and the pivotal phase 3 ENVISION clinical trial. Dr. Prasad shares insights from the study, the burden of recurrence for patients, and what a new treatment option may mean for patients....
info_outline
Navigating Low-Grade Upper Tract Urothelial Cancer: A Patient’s Journey
The UroGist
In this episode of The UroGist, host Dr. Mike Louie of UroGen is joined by Dr. Pascal de Caprariis, a patient with low-grade upper tract urothelial cancer (LG-UTUC) and an infectious disease specialist. Dr. de Caprariis shares his unique perspective as both a physician and a person living with LG-UTUC, discussing his diagnosis, treatment journey, and offering advice to others facing similar challenges. Documents to link in episode description: For users listening from their desktop device, please click on the link below to access clickable...
info_outline
Ep. 3: Bringing Real World Data to the Clinic with Dr. Yair Lotan
The UroGist
In this episode of The UroGist, host Dr. Mike Louie of UroGen sits down with guest Dr. Yair Lotan, Chief of Urologic Oncology at UT Southwestern Medical Center and Medical Director of the Urology Clinic at UT Southwestern and Parkland Health and Hospital System for an in-depth look at data derived from real-world patient experiences, insights into the latest real-world evidence and how this information helps shape the future of urologic oncology. Documents to link in episode description: For users listening from...
info_outline
Ep. 2: Antegrade Administration with Dr. Jennifer Linehan
The UroGist
In this episode of The UroGist, host Dr. Mike Louie of UroGen sits down with guest Dr. Jennifer Linehan, an Associate Professor of Urologic Oncology and Section Head of Urology Translational Research at the St. John's Cancer Institute in Santa Monica, CA to discuss the nuances of antegrade administration of an innovative treatment for low-grade upper tract urothelial cancer. While discussing the OLYMPUS study, the episode refers to 84% durability for 12 months for patients with low-grade upper tract urothelial cancer, which was found in interim data. The final durability of response...
info_outline
Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray
The UroGist
In this inaugural episode of The UroGist, host Dr. Mike Louie of UroGen Pharma welcomes guest Dr. Katie Murray, Professor at NYU Langone Health as well as the Chief of Urology Service at Bellevue Hospital Center, for an informative chat about personalized treatment, management, and subsequent challenges for low-grade upper tract urothelial cancer (LG-UTUC) patients.
info_outlineIn this inaugural episode of The UroGist, host Dr. Mike Louie of UroGen Pharma welcomes guest Dr. Katie Murray, Professor at NYU Langone Health as well as the Chief of Urology Service at Bellevue Hospital Center, for an informative chat about personalized treatment, management, and subsequent challenges for low-grade upper tract urothelial cancer (LG-UTUC) patients.